D-0827-2020 Class III Terminated
FDA drug recall D-0827-2020 was initiated by Ascend Laboratories LLC on Jan 22, 2020 and is designated Class III. Reason for recall: Failed Dissolution Specifications: low out of specification results for dissolution testing. The recall status is terminated (terminated Oct 27, 2021). Affected quantity: 4728 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 12, 2020
- Initiation Date
- Jan 22, 2020
- Termination Date
- Oct 27, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4728 bottles
Product description
Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-438-30.
Reason for recall
Failed Dissolution Specifications: low out of specification results for dissolution testing.
Distribution pattern
Nationwide in the USA
Code information
Lot #: 19140414, Exp 12/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0827-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026